NASDAQ: MLYS Mineralys Therapeutics, Inc. 8-K

Mineralys Therapeutics holds routine annual meeting, elects three directors

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MLYS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 25, 2026 7:36 PM